Medtronic, Inc. (MDT)
-NYSE | Prev Close: | 51.46 |
|---|
| Open: | N/A |
|---|
| Bid: | 50.76 x 200 |
|---|
| Ask: | 52.67 x 200 |
|---|
| 1y Target Est: | 50.29 |
|---|
| Beta: | 1.02 |
|---|
| Next Earnings Date: | 20-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 35.67 - 53.83 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 4,356,670 |
|---|
| Market Cap: | 52.17B |
|---|
| P/E (ttm): | 15.22 |
|---|
| EPS (ttm): | 3.38 |
|---|
| Div & Yield: | 1.04 (2.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Dividend Growth Gem Medtronic Is A Cash Cowat Seeking Alpha(Fri 4:39AM EDT)
- Final Glance: Medical Devices companiesAP(Thu, May 23)
- [$$] Big Profits From Bad Backsat Barrons.com(Thu, May 23)
- Are These Tuesday Post-Earning Movers a Buy?at Motley Fool(Thu, May 23)
- Thursday 5/23 Insider Buying Report: MDT, WDat Forbes(Thu, May 23)
- Midday Glance: Medical Devices companiesAP(Thu, May 23)
- McDonald’s Initiates a Dividend, Seagate Gets An Upgrade, and 3 More Hot Stocksat Wall St. Cheat Sheet(Thu, May 23)
- Early Glance: Medical Devices companiesAP(Thu, May 23)
- Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant HypertensionThomson Reuters ONE(Thu, May 23)
- Medtronic's In.Pact Falcon yields positive outcomes in small coronary arteriestheflyonthewall.com(Thu, May 23)
- Medtronic CoreValve® System Gains First Approval for Transcatheter Valve-In-Valve ProceduresThomson Reuters ONE(Thu, May 23)
- InPlay: Medtronic's In.Pact Falcon Drug-Eluting Balloon yields positive outcomes in small coronary arteriesBriefing.com(Thu, May 23)
- Medtronic's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary ArteriesThomson Reuters ONE(Thu, May 23)
- Medtronic Earnings Call Insights: Emerging Markets Analysis and CRM Businessat Wall St. Cheat Sheet(Wed, May 22)
- Medtronic's Defibrillator Sales Show A Pulse With Encouraging Resultsat Seeking Alpha(Wed, May 22)
Key Statistics
| Forward P/E (1 yr): | 13.40 |
|---|
| P/S (ttm): | 3.18 |
|---|
| Ex-Dividend Date: | 03-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Apr-13)
: | 3.69 |
|---|
| Quarterly EPS Est
(Apr-13)
: | 1.03 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.07 |
|---|
Business Summary
Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It provides products to diagnose, treat, and manage heart rhythm disorders and heart failure, including implantable cardiac pacemakers, implantable cardioverter defib...
View More